Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 28, 2023; 29(32): 4873-4882
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4873
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4873
Figure 1 Comparative performance of each prognostic score for predicting decompensation at 3 years.
FIB-4: Fibrosis-4; MELD: Model for end-stage liver disease; ALBI: Albumin-bilirubin.
- Citation: Navadurong H, Thanapirom K, Wejnaruemarn S, Prasoppokakorn T, Chaiteerakij R, Komolmit P, Treeprasertsuk S. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. World J Gastroenterol 2023; 29(32): 4873-4882
- URL: https://www.wjgnet.com/1007-9327/full/v29/i32/4873.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i32.4873